The Koch Institute for Integrative Cancer Research at MIT

Mosaic of colored tiles and images of research and people

Celebrating 50 years of collaboration, innovation, and curiosity in cancer research at MIT

Join us 

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer. 

Detection & monitoring  
Metastasis  
Immunology & immunotherapy  
Nano-based drugs  
Precision medicine  

News

Microfluidic device reveals leukemia cell behaviors in the blood

MIT Koch Institute

April 20, 2024

Scott Manalis and Michael Hemann published a new study in Communications Biology that improves our basic understanding of circulating leukemia cell dynamics over the course of disease progression and therapeutic response.

Understanding these circulation kinetics and clearance rates can inform our biological understandings of metastasis, as well as the design of tools that target these circulating cells for cancer diagnosis, treatment and monitoring.

Meet the 2024 Amon Award Winners

MIT Koch Institute

The Koch Institute at MIT is pleased to announce the winners of the 2024 Angelika Amon Young Scientist Award, Anna Uzonyi and Lukas Teoman Henneberg. 

Cancer moonshot boosts CisionVision

PR Newswire

CisionVision, co-founded by KI’s Angela Belcher and former trainee and Convergence Scholar Jeremy Li, has secured up to $22 million from the Advanced Research Projects Agency for Health (ARPA-H) Precision Surgical Interventions (PSI) program.

More News 

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.